QDEL - Plexus collaborates with Quidel Corporation to scale the Sofia2 product

In order to support increased demand for point-of-care testing used in the fight against COVID-19, Plexus (PLXS) will provide Supply Chain and Manufacturing Solutions to Quidel Corporation (QDEL) in support of the Sofia2 Fluorescent Immunoassay Analyzer. Sofia2 is Quidel’s best-selling cartridge-based rapid diagnostic system for infectious disease testing and has the power to deliver fast, highly accurate, objective and automated results, in 15 minutes or less, that aid in the diagnosis of many critical diseases and conditions, including: COVID-19, Influenza A+B, Strep A, Lyme Disease and Respiratory Syncytial Virus (RSV).Press release

For further details see:

Plexus collaborates with Quidel Corporation to scale the Sofia2 product